Medicare proposes cuts to hospital reimbursement for 340B drugs

Tara covers the enterprise of well being care. Her tales concentrate on hospitals, medical doctors, and the way their enterprise practices have an effect on sufferers — particularly when non-public fairness will get concerned. She additionally writes about medical health insurance and concepts for enhancing our damaged well being system. You’ll be able to attain Tara on Sign at tarabannow.70.

Medicare desires to slash funds to hospitals for medicine acquired by means of the 340B drug low cost program by greater than a 3rd starting subsequent 12 months, after the company stated its surveys discovered some sufferers paid extra for the medicine than the hospitals did. 

Underneath a proposal launched Thursday, Medicare would pay hospitals for 340B medicine at their common gross sales value minus 33.4%, dramatically lower than they’re getting at present, which is that value plus 6%. The availability, a part of a proposed rule on hospital outpatient funds, represents the newest swing at what’s grow to be a hotly debated drug low cost program, seen by some as a lifeline for safety-net hospitals and by others as a revenue middle for rich well being programs. 

The proposal drew swift condemnation from teams representing nonprofit and tutorial hospitals, who stated it could disproportionately hurt safety-net suppliers. That’s as a result of solely these nonprofit amenities are eligible for 340B, whereas for-profit hospitals usually are not. Medicare’s proposed rule exhibits a 7.4% pay improve to for-profit hospitals below the 340B adjustment.